MIRA INFORM REPORT

 

 

Report No. :

320867

Report Date :

08.05.2015

 

IDENTIFICATION DETAILS

 

Name :

EGYPTIAN CO FOR CHEMICALS & PHARMACEUTICALS SAE (ADWIA)

 

 

Registered Office :

Adwia Administration Building, 1st Industrial Zone, Al Obour City, PO Box 59, Cairo

 

 

Country :

Egypt

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

1984

 

 

Com. Reg. No.:

50195

 

 

Legal Form :

Egyptian Joint Stock Company

 

 

Line of Business :

Engaged in the manufacture of human and veterinary pharmaceuticals, animal feed concentrates, pesticides and agriculture pesticides.

 

 

No. of Employees :

300

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

Payment Behaviour :

Regular

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Egypt

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

EGYPT - ECONOMIC OVERVIEW

 

Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 pursued business climate reforms to attract foreign investment and facilitate growth. Poor living conditions and limited job opportunities for the average Egyptian contribute to public discontent, a major factor leading to the January 2011 revolution that ousted Mubarak. The uncertain political, security, and policy environment since 2011 caused economic growth to slow significantly, hurting tourism, manufacturing, and other sectors and pushing up unemployment. Weak growth and limited foreign exchange earnings have made public finances unsustainable, leaving authorities dependent on expensive borrowing for deficit finance and on Gulf allies to help cover the import bill.

 

Source : CIA


SUMMARY

 

Company Name                                    : EGYPTIAN CO FOR CHEMICALS & PHARMACEUTICALS SAE

  (ADWIA)

Country of Origin                                   : Egypt

Legal Form                                           : Egyptian Joint Stock Company

Registration Date                                  : 1984

Commercial Registration Number           : 50195

Authorised Capital                                 : £E 1,000,000,000

Issued Capital                                       : £E    350,000,000

Paid up Capital                                     : £E    350,000,000

Total Workforce                                     : 300

Activities                                               : Manufacturers of human and veterinary pharmaceuticals, animal feed

                                                              concentrates, pesticides and agriculture pesticides.

Financial Condition                                : Fair

Payments                                             : Nothing detrimental uncovered

Operating Trend                                    : Steady

Person Interviewed                                : Emad Soltan, Accounts Manager

 

 

COMPANY NAME

 

EGYPTIAN CO FOR CHEMICALS & PHARMACEUTICALS SAE (ADWIA)

 

 

ADDRESS

 

Registered & Physical Address

 

Building            : ADWIA Administration Building

Area                 : 1st Industrial Zone, Al Obour City

PO Box            : 59

Town                : Cairo

Country             : Egypt

Telephone         : (20-2) 26597500 / 44812444

Facsimile          : (20-2) 26597520

Mobile              : (20-100) 1679064

Email                : adwia@adwia.com / adwia_exp@menanet.net / export@adwia.com / emad.soltan@adwia.com

 

Premises

 

Subject operates from a large suite of offices and a warehouse that are owned and located in the Industrial Area of Cairo.

 

Branch Office (s)

 

Location                                                                                   Description

 

1st Industrial Zone A2, Area 211                                                  Owned factory premises

Khoufo Street

Sharkeya

Tenth of Ramadan City

Tel: (20-15) 413104/5/6/7/8 / 362476 / 362475

Fax: (20-15) 413105/7 / 363635

 

30 Mohamed Said El Halawani Street                                         Sales Office

Heliopolis

Cairo

Tel: (20-2) 2667596 / 2667476 / 2667469

Fax: (20-2) 2667596 / 2673696

 

El Nile Building                                                                          Sales Office

El Gueish Street

Al Mansoura

Tel: (20-50) 314340

 

Gamal Abdel Nasser Street                                                        Sales Office

Al Fayoum

Tel: (20-84) 352794

 

Abdel Salam El Shazly Street                                                     Sales Office

Damanhour

Tel: (20-45) 353069

 

Sour El Estad El Riyady                                                            Sales Office

Kafr El Sheikh

Tel: (20-47) 236016

 

61 El Gueish Street                                                                    Sales Office

Tanta

Tel: (20-40) 314839

 

 

KEY PRINCIPALS

 

Name                                                                                       Position

 

Hossam El Din Mohamed Taher                                                 Managing Director

 

Sameh Mohamed Taher                                                             Director

 

Ashraf Mohamed Taher                                                              Director

 

Hisham Mohamed Taher                                                            Director

 

Emad Soltan                                                                             Accounts Manager

 

Rabih Kamal                                                                             Finance Manager

 

Dr  Mohamed Sultan                                                                  Sales Manager – Animal Health

 

Dr Yusri Abdallah                                                                      Sales Manager – Pharmaceuticals

 

Dr Khalid El Fouli                                                                      Sales Manager – Pesticides

 

Dr Ahmed Samir                                                                        Factory Manager

 

Dr Amer El Jundy                                                                      Export Manager

 

Waheed Abu Dahab                                                                  Business Development Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 1984

 

Legal Form                  : Egyptian Joint Stock Company

 

Commercial Reg. No.   : 50195

 

Authorised Capital       : £E 1,000,000,000

 

Issued Capital              : £E 350,000,000

 

Paid up Capital            : £E 350,000,000

 

Name of Shareholder (s)                                               Percentage

 

Hossam El Din Mohamed Taher                                          80%

 

Sameh Mohamed Taher                                                 ]      

                                                                                    ]

Ashraf Mohamed Taher                                                  ]    

]     20%

Hisham Mohamed Taher                                                ]      

                                                                                    ]

Other private shareholders                                             ]

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of human and veterinary pharmaceuticals, animal feed concentrates, pesticides and agriculture pesticides.

 

Subject is ISO 14001 and 9001 accredited.

 

Import Countries: Germany and India

 

Export Countries: Subject exports throughout the Middle East, Africa, and Asia, as well as Albania and Malta

 

Brand Names: ADWIA

 

Operating Trend: Steady

 

Subject has a workforce of approximately 300 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Egyptian Pounds (£E)

 

                                                Year Ending 31/12/13:              Year Ending 31/12/14:

 

Total Sales                                £E 275,029,209                         £E 258,849,584

 

Local sources consider subject’s financial condition to be Fair.

 

The above figures were provided by Mr Emad Soltan, Accounts Manager

 

 

BANKERS

 

Commercial International Bank (CIB)

Nile Tower Building

21-23 Giza Street

PO Box: 2430

Cairo

Tel: (20-2) 25703043

Fax: (20-2) 25703172 / 25072691

 

Banque du Caire SAE

19 Adly Street

Cairo

Tel: (20-2) 33926915

Fax: (20-2) 33951713

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

Egyptian Co for Chemicals & Pharmaceuticals (Adwia) was established in 1984 and has gained a good reputation for the quality of its products. The company specialises in the manufacture of human and veterinary pharmaceuticals, animal feed concentrates, pesticides and agriculture pesticides.

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.88

UK Pound

1

Rs.97.21

Euro

1

Rs.72.51

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

TPT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.